Is Liraglutide legal in Indiana?
Since 1 Jul 2026 Indiana law (IC 16-42-22.5) bars compounding from research-grade or veterinary-grade bulk ingredients outside an IRB-approved study and requires an FDA-registered source with a certificate of analysis. From 1 Jan 2027 medical spas must register with the state medical board. Federally: Yes, as a prescription drug: FDA has approved it (Victoza, Saxenda, generics). A vial sold as a 'research peptide' is not the approved product, and selling it for human use breaks federal drug law. Pharmacies may compound it only when the product is not a copy of the approved drug.
CATEGORY · FDA APPROVED
Full status breakdown
FEDERAL · STATE · SPORT-BODYFederal status
Indiana — state-specific
Since 1 Jul 2026 Indiana law (IC 16-42-22.5) bars compounding from research-grade or veterinary-grade bulk ingredients outside an IRB-approved study and requires an FDA-registered source with a certificate of analysis. From 1 Jan 2027 medical spas must register with the state medical board.
- Indiana Senate Enrolled Act 282 (Public Law 136-2026), signed 5 Mar 2026 ↗ · verified Oct 12, 2026
- SEA 282 enrolled text ↗ · verified Oct 12, 2026
Sport-body status
What we couldn’t verify
Also known as
4 ALIASESLiraglutide is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):
SaxendaVictozaNN2211Lira
Related
FOLLOW-ONS- Are peptides legal in the US? — all 44 compounds in one table
- Peptide pricing index — what each compound costs per mg across audited vendors
- Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?
Liraglutide: US status, sources and what changed
Other states with a rule that names Liraglutide: California. Everywhere else, federal law applies.